Serum microRNA-29 family as potential biomarkers for cognitive impairment in Parkinson’s disease
Objective: To examine whether miRNA-29s (miR-29s) in serum could be used as biomarkers for either Parkinson’s disease with dementia (PDD) or Parkinson’s disease with mild…Functional connectivity traits in Parkinson’s disease mild cognitive impairment
Objective: Our objective is to assess functional networks in PD mild cognitive impairment (PD-MCI) and their contribution to global connectivity combining Connectome ICA (connICA) and…Non-motor Symptoms in Advanced- vs Non-advanced Parkinson’s Disease: A Subgroup Analysis of the OBSERVE-PD Observational Study
Objective: To report intercountry differences in non-motor symptoms in patients with advanced Parkinson’s Disease (APD) vs non-APD. Background: There is no standard criteria for the…Cognitive Differences Between Men and Women with Progressive Supranuclear Palsy
Objective: (1) To evaluate the cognitive differences between men and women with progressive supranuclear palsy (PSP) and (2) to investigate whether sex has an effect…Physiotherapy: Functionality and Cognition in Parkinson’s Disease
Objective: This study aimed to investigate if there is any association between physical activity score and cognitive impairment in people with Parkinson’s disease (PD). Background:…Speech is a sensitive marker in premanifest Huntington’s disease: exploring acoustic, cognitive and fine motor performance
Objective: To explore the utility of objective analysis of speech as a quantifiable clinical biomarker in premanifest HD. Background: The autosomal dominant inheritance of Huntington’s…Subjective Cognitive Complaints in early Parkinson’s Disease patients with normal cognition are associated with affective symptoms
Objective: To determine the prevalence of Subjective Cognitive Complaints (SCC) in early Parkinson’s disease (PD) and examine the correlates between SCC in early PD and…Alexithymia, Depression, and Cognition in Patients with Parkinson’s disease
Objective: The aim of our study is to examine the relation of alexithymia with cognition and depression in non-demented patients with Parkinson's disease (PD). Background:…Parkinson’s Disease Clinical Subtypes: Symptom Progression, Dementia, and Mortality
Objective: Identify Parkinson's disease (PD) clinical subtypes using multi-domain classification; determine subtype symptom progression; assess subtype clinical utility. Background: People with PD present with combinations…Investigating Factors Contributing to Parkinson’s disease-related Cognitive Decline
Objective: The objective of this study was to identify predictive factors of cognitive decline in patients with Parkinson’s disease (PD). Background: Among those with PD,…
- « Previous Page
- 1
- …
- 47
- 48
- 49
- 50
- 51
- …
- 117
- Next Page »